Improving access to our anticancer product in India

A program to improve patients’ access to our anticancer product in India

What are the health needs and challenges?

With changes in lifestyle-related behavior, the incidence rate of prostate cancer is constantly and rapidly increasing in India. Some cancer projection data show that the number of cases will double by 2020 (as compared to 2012).

In India, most patients have to pay the full cost of purchasing prescription. 

Description of partnership activities and how they address needs and challenges

Astellas is introducing a new program structured according to patients’ income levels to improve patients’ access to our anticancer product in India, in collaboration with local partners. It is believed that this new program will increase the number of patients able to access our product in India. Astellas recognizes that the affordability of medicines is one aspect impacting patients’ Access to Health. We will continue exploring various solutions which improve patients’ access to our products.

Partnership information

Company(ies) Astellas

Partner(s) Local associations

Type of Partner(s) Professional Associations

Therapeutic Focus Non-Communicable Diseases

Disease(s) Cancer

Program Type(s) Availability of Treatment - Differential Pricing

Region(s) South Asia

Number of Countries 1

Country(ies) India

Start Date 2017

Anticipated completion date Ongoing

« Astellas will continue exploring various solutions which improve patients’ access to our products. »